According to a report from Israeli business publication `Globes,' US tech biggie Apple will be opening a new Research & Development center in Ra'anana, Israel, later this year.
The new development center will be opened in the Ra'anana Industrial Zone in "the second half of 2013"; and will be Apple's third development center in the country. The company already has centers in Haifa and Herzliya; and the new center in Ra'anana will be located on the northern side of metropolitan Tel Aviv.
The new Apple R&D center in Israel will reportedly have 100-150 employees, mostly those who lost their jobs at chipmaker Texas Instruments (TI) a few weeks back, after TI's decision to slash the jobs of 250 of its employees. The majority of the employees whose jobs were axed by Texas were working at the company's Israel development center.
Going by the `Globes' report, Apple had hired the ex-TI employees late last year, after they were dismissed by TI as a part of its broad move to cull 1,700 employees across the world.
Though some earlier reports have revealed that the ex-TI employees hired by Apple had been chiefly working on short-range communication technologies like Wi-Fi, Bluetooth, and NFC, the `Globes' report suggests that the course which Apple has strategically worked out for the new development center will be an entirely different one.
Chinese device manufacturer Lenovo officially unveiled the world's first ‘Project Tango’ Android-powered smartphone at its 2016 Tech World event this week.
The new Lenovo handset – which boasts support for Google’s Tango futuristic...
A new study by the Massachusetts Institute of Technology (MIT) has revealed that Istanbul lies...
During the course of Thursday proceedings in the ongoing legal scuffle between Google and Oracle...
Paying in cash is any day better than taking a loan from a loan shark. In good old days people used a wad of cash to pay everything starting from furniture to grocery, if they did not have enough, they would wait for something cheaper or for the...
In January, trade surplus of Germany decreased since plunge in imports was more than a drop in...
In an apparent attempt to enhance the visual experience for Google search users carrying out...
German drugmaker Merck said that its experimental cancer medicine evofosfamidehas failed in the last stage of clinical tests due to which it won't seek regulatory approval for its treatment.
On Monday, Darmstadt, Germany-based Merck said...
In an announcement made on Thursday, electric vehicle...
The Verge has revealed in a Wednesday report, citing a...
In a recently released blog post, tech biggie Google has...
In a recently-issued warning to civilian aviators, the...
© 2011 AustrianTribune - Tribune Online Services. All times CET (GMT + 1.00).